C44H46FN9O5 — CID 166117033
5-tert-butyl-N-[[4-[6-[5-[[4-[2-[4-(2,6-dioxopiperidin-3-yl)oxyphenyl]ethyl]piperidin-1-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide (PubChem CID 166117033) has the molecular formula C44H46FN9O5 and a molecular weight of 799.91 g/mol. Its IUPAC name is 5-tert-butyl-N-[[4-[6-[5-[[4-[2-[4-(2,6-dioxopiperidin-3-yl)oxyphenyl]ethyl]piperidin-1-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide.
| Compound Name | 5-tert-butyl-N-[[4-[6-[5-[[4-[2-[4-(2,6-dioxopiperidin-3-yl)oxyphenyl]ethyl]piperidin-1-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
|---|---|
| PubChem CID | 166117033 |
| Molecular Formula | C44H46FN9O5 |
| Molecular Weight | 799.91 g/mol |
| Exact Mass | 799.36 |
| IUPAC Name | 5-tert-butyl-N-[[4-[6-[5-[[4-[2-[4-(2,6-dioxopiperidin-3-yl)oxyphenyl]ethyl]piperidin-1-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
| SMILES | CC(C)(C)c1nc(C(=O)NCc2ccc(-c3ncnn4cc(-c5ccc(CN6CCC(CCc7ccc(OC8CCC(=O)NC8=O)cc7)CC6)cn5)cc34)cc2F)no1 |
| InChI | InChI=1S/C44H46FN9O5/c1-44(2,3)43-51-40(52-59-43)42(57)47-23-31-10-9-30(20-34(31)45)39-36-21-32(25-54(36)49-26-48-39)35-13-8-29(22-46-35)24-53-18-16-28(17-19-53)5-4-27-6-11-33(12-7-27)58-37-14-15-38(55)50-41(37)56/h6-13,20-22,25-26,28,37H,4-5,14-19,23-24H2,1-3H3,(H,47,57)(H,50,55,56) |
| InChIKey | BSBNAZCGLJUFOQ-UHFFFAOYSA-N |
| XLogP | 6.24 |
| TPSA | 169.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 59 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 799.91 |
| LogP ≤ 5 | 6.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|